Dimeric C34 Derivatives Linked through Disulfide Bridges as New HIV‐1 Fusion Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dimeric C34 Derivatives Linked through Disulfide Bridges as New HIV‐1 Fusion Inhibitors

Published:2019-07-04 Issue:16 Volume:20 Page:2101-2108
ISSN:1439-4227
Container-title:ChemBioChem
language:en
Short-container-title:ChemBioChem

Author:

Kobayakawa Takuya¹,Ebihara Kento¹,Honda Yuzuna¹,Fujino Masayuki²,Nomura Wataru¹,Yamamoto Naoki³,Murakami Tsutomu²,Tamamura Hirokazu¹^ORCID

Affiliation:

1. Institute of Biomaterials and BioengineeringTokyo Medical and Dental University (TMDU) 2-3-10 Kandasurugadai Chiyoda-ku Tokyo 101-0062 Japan

2. AIDS Research CenterNational Institute of Infectious Diseases 1-23-1 Toyama Shinjuku-ku Tokyo 162-8640 Japan

3. Yong Loo Lin School of MedicineNational University of Singapore Singapore 117597 Singapore

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Organic Chemistry,Molecular Biology,Molecular Medicine,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cbic.201900187

Reference45 articles.

1. The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

2. Current status and prospects of HIV treatment

3. HIV-1 Antiretroviral Drug Therapy

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins;Chemical and Pharmaceutical Bulletin;2024-01-01

2. Structure and Function of the SARS-CoV-2 6-HB Fusion Core and Peptide-Based Fusion Inhibitors: A Review;Current Medicinal Chemistry;2023-11-24

3. Dimerized fusion inhibitor peptides targeting the HR1–HR2 interaction of SARS-CoV-2;RSC Advances;2023

4. Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins;RSC Advances;2023

5. Hybrids of small CD4 mimics and gp41-related peptides as dual-target HIV entry inhibitors;Bioorganic & Medicinal Chemistry;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3